ATEX · Stage, GEX levels and seasonality

Anterix Inc. Common Stock (ATEX)

Last close $78.50 (-0.68%) on 2026-09-30

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Open the chart

Weinstein stage

Stage 2A — Advancing · 33 weeks in this stage · 30-week average $70.60

Stage 2 (advancing): price holds above a rising 30-week average. The stage Weinstein buys.

What would change it: Stage 3 warning if the 30-week SMA (70.6) stops rising and price starts closing below it.

GEX levels

Call wall, put wall and gamma flip for ATEX are on Signa plans. What GEX levels tell you.

Seasonality

MonthAverage returnMonths upYears
January+5.26%50%4
February+21.52%75%4
March-2.62%50%4
April+0.47%25%4
May+6.66%75%4
June+18.49%50%4
July-8.65%0%4
August+1.25%50%4
September-2.97%25%4
October (this month)-5.93%33%3
November+5.49%100%3
December-2.59%33%3

Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.

On Signa plans

The Signa score and Action Card for ATEX, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Questions about ATEX

What Weinstein stage is ATEX in?

ATEX is in Stage 2A — Advancing, for 33 weeks, based on completed weekly bars and its 30-week moving average (70.60).

How has ATEX done in October?

Over the last 3 years, ATEX averaged -5.93% in October and rose in 33% of them. Past seasonality does not predict future returns.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.